Received Apr 22, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | UNK | Y008077 | — |
No additional AE; expired administration of MMR II; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's medical history, historical dugs, concurrent conditions, past drug adverse reactions or allergies and concomitant drugs were not reported. On 20-APR-2026, the patient was vaccinated with Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) (0.5 mL / two dose series, lot#: Y008077, expiration date: 19-APR-2026; route of administration was not reported) for prophylaxis (expired vaccine used). This vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT) (lot# and expiration date were not reported). No additional adverse events (AE) were reported (no adverse event).
sterile diluent